(HealthDay News) -- Here are the latest clinical trials,
This study of moderate-to-severe plaque psoriasis will compare
an investigational combination of two FDA-approved drugs with a
single approved psoriasis medication.
The research site is in Denver, Colo.
To qualify for this study, candidates must be aged 21 to 64,
have trouble staying asleep, and be in general good health.
The research site is in New York City.
This 12-week study will evaluate the safety and effectiveness of
the study drug in eliminating hot flashes in post-menopausal women.
Participants must be 40 or older and have 50 to 60 hot flashes per
The research site is in Sacramento, Calif.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.